Category: Biotechnology
Biotechnology market research reports by Roots Analysis
-
Bacteriophage Therapeutics Market, 2022-2035
Bacteriophage Therapeutics Market, 2022-2035 Antimicrobial resistance (AMR) has been identified as one of the greatest threats to public health. According to the Centers of Disease Control and Prevention, more than 2.8 million cases of AMR infections are identified in the United States on an annual ... Read More
-
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape
Microbiome Therapeutics and Diagnostics: Intellectual Property Landscape More than 10,000 unique species of microorganisms make up the human microbiome; in fact, the total number of microbial cells in the human body is known to vastly outnumber the indigenous cellular population. Of late, many studi ... Read More
-
Rare Kidney Disorders Market, 2022-2035
Rare Kidney Disorders Market, 2022-2035 The term rare kidney diseases represents around 150 different indications. It is worth highlighting that the prevalence rate of rare kidney disorders (RKD) is estimated to be 60-80 per 100,000 cases / individuals in the US and Europe. Despite their relatively ... Read More
-
Organ-on-chip Market, 2022-2035: Focus on Products and Technologies
Organ-on-chip Market, 2022-2035: Focus on Products and Technologies It is a well-known fact that almost 90% of the therapeutic interventions fail in clinical trials, resulting in significant economic losses to the pharmaceutical industry. The lack of effective preclinical prediction of drug respons ... Read More
-
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035
Adeno-Associated Viral (AAV) Vector Market: Focus on Drugs, Manufacturers and Technologies, 2022-2035 Given the potential of gene therapies in targeting the underlying cause of a disease at cellular level, the demand for such therapies has increased considerably over the past few years. Currently, ... Read More
-
NAMPT Inhibitors Market, 2022-2040
NAMPT Inhibitors Market, 2022-2040 Globally, cancer is one of the leading causes of death; in 2020, about 10 million cancer related deaths were reported. Further, according to a study published in American Cancer Society Journal, by 2040, the number of cancer cases is projected to reach over 28 mil ... Read More
-
CRISPR Technologies: Intellectual Property Landscape
CRISPR Technologies: Intellectual Property Landscape Over the last two decades, genome editing concepts and genetic engineering have evolved significantly, with the development of a variety of versatile DNA modulation technologies, including clustered, regularly interspaced short palindromic repeats ... Read More
-
Tissue Engineering-based Regeneration Products Market, 2022-2035
Tissue Engineering-based Regeneration Products Market, 2022-2035 Research indicates that about 6% of the individuals are expected to get affected from chronic wounds, globally. Specifically, in the US, 6.5 million individuals are estimated to be affected by chronic wounds. Financially, treatment of ... Read More
-
Mini Bioreactors and Micro Bioreactors Market, 2022-2035
Mini Bioreactors and Micro Bioreactors Market, 2022-2035 With several blockbuster therapies (such as Humira®, Rituxan®, Lantus®, Avastin®, Herceptin® and Remicade®) and a robust pipeline of product / therapy candidates, the biopharmaceutical market is anticipated to witness significant growth in the ... Read More
-
RNA Extraction and Purification Kits, Reagents, and Instruments Market, 2022-2035
RNA Extraction and Purification Kits, Reagents, and Instruments Market, 2022-2035 Over the last few decades, there have been significant advancements in the field of molecular biology. In this domain, molecular diagnostic testing has emerged an important tool for disease diagnosis and monitoring. In ... Read More
-
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035
RNAi Therapeutics and Technology Market (3rd Edition): Focus on siRNA, miRNA, shRNA, sshRNA and DNA, 2022-2035 INTRODUCTION RNAi therapeutics have garnered significant attention post the 2006 Nobel Prize that was awarded to Andrew Fire and Craig Mello for the discovery of RNA interference (RNAi). Su ... Read More
-
Investor Series: Opportunities in the Cell and Gene Therapy Market
Investor Series: Opportunities in the Cell and Gene Therapy Market Contemporary medical science has traced thousands of clinical conditions to a genetic cause. Cancer, a life-threatening disease, also has genetic origins, and is considered among the leading causes of death across the globe. In fact, ... Read More
-
Gene Therapies & Associated Vectors: Intellectual Property Landscape
Gene Therapies & Associated Vectors: Intellectual Property Landscape Although speculations related to using tailored DNA / RNA sequences to cure genetic disorders were made as early as the 1960s, the first reported use of a gene therapy was in 1990, to treat adenosine deaminase (ADA) deficiency rela ... Read More
-
CAR-T Cell Therapies: Intellectual Property Landscape
CAR-T Cell Therapies: Intellectual Property Landscape Cancer, one of the leading causes of death worldwide, claimed close to 10 million lives annually Although there are several treatment options available to control disease progression and keep malignant cells from spreading throughout the body, l ... Read More
-
Viral Vaccine Cell Culture Media Market, 2022-2035
Viral Vaccine Cell Culture Media Market, 2022-2035 Over the past few years, a number of advanced vaccines targeting a myriad of disease indications have received approval from various regulatory authorities. Post the onset of COVID-19, there has been a surge in the demand for viral vaccines. In fac ... Read More
-
Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035
Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035 Since the approval of Orthoclone OKT3, a murine monoclonal antibody against T cell expressed CD3 (for the treatment of acute transplant rejection) in 1986, antibody based pharmacological interventions have evolved into a promi ... Read More
-
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis Optica and Paroxysmal Nocturnal Hemoglobinuria), Therapeutic Area (Cardiovascular, Genetic, Hematological and Vascular, Infectious, Neurological and Neuromuscular Disorders), Type of Molecule (Biologic and Small Molecule), Target Pathway (Alternate, Classical, Lectin and Terminal Pathway), Type of Therapy (Monotherapy and Combination Therapy), Route of Administration (Intravenous, Oral and Subcutaneous), Key Geographical Regions (North America, Europe and Asia-Pacific): Industry Trends and Global Forecasts, 2022-2035
Next Generation Complement Therapeutics Market, 2022-2035: Distribution by Target Disease Indication (Atypical Hemolytic Uremic Syndrome, Cardiac Transplantation Rejection, Cold Agglutinin Disease, COVID-19, Generalized Myasthenia Gravis, Guillain-Barre Syndrome, Hereditary Angioedema, Neuromyelitis ... Read More
Research Assistance
